Genetic variants of CTLA4 are associated with clinical outcome of patients with multiple myeloma Front Immunol
Survival of patients with mantle cell lymphoma in the rituximab era: Retrospective binational analysis between 2000 and 2020 BRIT J HAEMATOL
An epigenetic switch controls an alternative NR2F2 isoform that unleashes a metastatic program in melanoma Nat Commun
VHrare study: Prevalence, clinical features and management of severe rare bleeding disorders in a large cohort BRIT J HAEMATOL
T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo PHARMACEUTICS
Effect of CD34+Cell Dose on the Outcomes of Allogeneic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide TRANSPL CELL THER
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS BLOOD CANCER J